ecteinascidin 743 has been researched along with Response Evaluation Criteria in Solid Tumors in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfaro, V; Blum, JL; Byrski, T; Campone, M; Cullell-Young, M; Delaloge, S; Ghouadni, A; Gonçalves, A; Kahatt, C; Lardelli, P; Lubinski, J; Nieto, A | 1 |
| Bompas, E; Clisant, S; Guillemet, C; Italiano, A; Maynou, C; Penel, N; Peugniez, C; Piperno-Neumann, S; Ryckewaert, T; Saada-Bouzid, E; Taieb, S; Thyss, A; Tresch, E | 1 |
| Badalamenti, G; Bello, E; Casali, PG; Collini, P; Colombo, C; Cominetti, D; D'Incalci, M; Dagrada, GP; Dei Tos, AP; Frapolli, R; Gronchi, A; Morosi, C; Negri, T; Pilotti, S; Provenzano, S; Renne, SL; Saponara, M; Stacchiotti, S; Tortoreto, M; Vincenzi, B; Zaffaroni, N; Zuco, V | 1 |
1 trial(s) available for ecteinascidin 743 and Response Evaluation Criteria in Solid Tumors
| Article | Year |
|---|---|
Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial.
Topics: Adult; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Ductal, Breast; Dioxoles; Female; Genes, BRCA1; Genes, BRCA2; Germ-Line Mutation; Heterozygote; Humans; Middle Aged; Response Evaluation Criteria in Solid Tumors; Tetrahydroisoquinolines; Trabectedin | 2017 |
2 other study(ies) available for ecteinascidin 743 and Response Evaluation Criteria in Solid Tumors
| Article | Year |
|---|---|
Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Dioxoles; Disease Progression; Drug Administration Schedule; Female; Humans; Image Processing, Computer-Assisted; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Sarcoma; Tetrahydroisoquinolines; Tomography, X-Ray Computed; Trabectedin; Young Adult | 2015 |
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cerebellar Neoplasms; Dacarbazine; Dioxoles; Disease-Free Survival; Doxorubicin; Female; Furans; Humans; Ifosfamide; Ketones; Kidney Neoplasms; Male; Meningeal Neoplasms; Mice, SCID; Middle Aged; Pleural Neoplasms; Response Evaluation Criteria in Solid Tumors; Retroperitoneal Neoplasms; Retrospective Studies; Soft Tissue Neoplasms; Solitary Fibrous Tumors; Survival Rate; Tetrahydroisoquinolines; Trabectedin; Xenograft Model Antitumor Assays | 2017 |